Quality Committee Archive

Related Files

  • Laboratory Genetic Units June 2014 - last updated Tuesday, 21st November 2017

  • Laboratory Genetic Units December 2012 - last updated Tuesday, 21st November 2017

  • Genetics EQA participants meeting agenda 2015 - last updated Tuesday, 21st November 2017

  • FH testing audit - last updated Tuesday, 21st November 2017

    Dear Head of lab,

    The British Heart Foundation and the National Familial Hypercholesterolaemia (FH) steering group have requested the help of the ACGS to measure the improvement in ascertainment of FH cases achieved from the current rounds of investment. Measuring the benefit of the programme is key to make an argument for sustained and hopefully extended commissioning for FH testing. The steering group understand the amount of work involved particularly in collecting retrospective data, but this is key to establishing a base line from which to measure improvement. Everyone's efforts will be greatly appreciated.

    The ACGS Quality Subcommittee would like to collect information from laboratories provided FH testing, thereforewe invite you to complete the attached survey.

    Please complete this electronic copy and email to Sandi Deans at Sandi.Deans@ed.ac.uk by 2nd October 2015.

    Thank you for your help.

    With best wishes,
    Sandi

     Dr Sandi Deans

    Chair - ACGS Quality Subcommittee

    Latest News

  • ClinGen/ACGS collaboration

    posted 5th February 2018  |  0 Comments

    Association for Clinical Genomic Science (ACGS) has entered into a formal affiliation with the ClinGen Inherited Cardiomyopathy Expert Panel (CMP-EP). We will be working jointly to adapt the ACMG/AMP variant classification guidelines for genes associated with hypertrophic cardiomyopathy (HCM). This work is an extension of the ClinGen CMP-EP's recommendations for MYH7 variant classification. ClinGen and ACGS have a shared goal of developing standardised genomic variant interpretation guidelines for improved patient care. The contribution of genomic and phenotypic data from both groups, as well as collaboration in the decision-making process, represents a first step in global development, acceptance, and use of a common set of specified guidelines.

    Read more